Stock In News: Signature Bank (NASDAQ:SBNY), OncoSec Medical (OTCMKTS:ONCS), Novartis AG (NYSE:NVS), Brown & Brown (NYSE:BRO)

Signature Bank (Nasdaq:SBNY), a New York-based full-service commercial bank, announced that it was the only large cap bank to be named on the Forbes list of America’s 50 Most Trustworthy Financial Companies. Signature Bank (NASDAQ:SBNY) shares after opening at $124.28 moved to $124.28 on last trade day and at the end of the day closed at $122.94. Company price to sales ratio in past twelve months was calculated as 7.50 and price to cash ratio as 20.61. Signature Bank (NASDAQ:SBNY) showed a positive weekly performance of 1.01%.

OncoSec Medical Inc. (OTCQB:ONCS), a company developing its ImmunoPulse DNA-based immunotherapy to treat solid tumors, has named Adil Daud, M.D. as Chief Clinical Strategist. OncoSec Medical Inc (OTCMKTS:ONCS) shares fell -6.41% in last trading session and ended the day on $0.730.

Novartis AG (ADR) (NYSE:NVS) announced plans to overhaul its business. The company plans to sell two units and buy another, in multiple transactions totaling $25 billion, which have the potential to increase to as much as $28.5 billion.  Novartis AG (ADR) (NYSE:NVS) shares moved up 1.29% in last trading session and was closed at $86.56, while trading in range of $86.18-$86.78. Novartis AG (ADR) (NYSE:NVS) year to date performance is 11.32%.

Brown & Brown, Inc. (NYSE:BRO) announced its unaudited financial results for the first quarter of 2014.  Brown & Brown, Inc. (NYSE:BRO) weekly performance is -0.52%. On last trading day company shares ended up $28.91. Brown & Brown, Inc. (NYSE:BRO) distance from 50-day simple moving average is -4.33%. Analysts mean target price for the company is $35.09.